Pharmaceutical composition for treating essential hypertension and application thereof

A technology for essential hypertension and a composition, which is applied in the field of medicine, can solve the problems of insufficient attention to target organ protection and reversal, and can inhibit the reduction of eNOS protein expression and eNOS gene expression in vascular tissue, and is suitable for long-term use. Effect
CN103751203BInactive Publication Date: 2016-08-31XINXIANG MEDICAL UNIV
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
XINXIANG MEDICAL UNIV
Publication Date
2016-08-31
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the technical field of medicine, particularly relates to a medicinal composition for treating essential hypertension and application thereof. The medicinal composition is prepared from the following raw materials: Lycium barbarum polysaccharide component II, Lycium barbarum polysaccharide component III, friedelin-3beta-ol, Astragalus polysaccharide component A1 and Ajugol A. The medicinal composition provided by the invention has obvious therapeutic effect of inhibiting clinical symptoms of essential hypertension, has the advantages of stable quality control, no toxicity and is suitable for long-term administration.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating essential hypertension and its application. Background technique

[0002] Essential hypertension is an independent disease with elevated blood pressure as the main clinical manifestation. Hypertension is a common and frequently-occurring disease that endangers human health. It can cause serious damage to important organs such as the heart, brain, and kidneys. According to the data provided by the Bureau of Disease Control and Prevention of the Ministry of Health of China, there are about 160 million patients in mainland China, and the control rate of people suffering from hypertension is only 6.1%. The etiology of hypertension has not been elucidated in modern medicine, so symptomatic treatment is usually adopted, and the drugs selected almost all have side effects in varying degrees, and there are obvious limitations in tre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More